Infiltration of M2 Macrophages and Regulatory T Cells Plays a Role in Recurrence of Renal Cell Carcinoma

European Urology Open Science - Tập 20 - Trang 62-71 - 2020
Sabina Davidsson1, Michelangelo Fiorentino2, Francesca Giunchi2, Margareta Eriksson3, Ann Erlandsson4, Pernilla Sundqvist1, Jessica Carlsson1
1Department of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
2Department of Pathology, Maggiore Hospital and S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
3Department of Clinical Pathology and Cytology, Central Hospital Karlstad, Karlstad, Sweden
4Department of Environmental and Life Sciences – Biology, Karlstad University, Karlstad, Sweden

Tài liệu tham khảo

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Wang, 2019, M2b macrophage polarization and its roles in diseases, J Leukoc Biol, 106, 345, 10.1002/JLB.3RU1018-378RR Murray, 2011, Obstacles and opportunities for understanding macrophage polarization, J Leukoc Biol, 89, 557, 10.1189/jlb.0710409 Erlandsson, 2019, M2 macrophages and regulatory T cells in lethal prostate cancer, Prostate, 79, 363, 10.1002/pros.23742 Yagi, 2019, Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer, Eur J Cancer, 111, 38, 10.1016/j.ejca.2019.01.018 Behnes, 2014, Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma, Virchows Arch, 464, 191, 10.1007/s00428-013-1523-0 Komohara, 2011, Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma, Cancer Sci, 102, 1424, 10.1111/j.1349-7006.2011.01945.x Ma, 2018, CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma, Med Mol Morphol, 51, 13, 10.1007/s00795-017-0165-8 Nishikawa, 2005, CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients, Blood, 106, 1008, 10.1182/blood-2005-02-0607 Nishikawa, 2014, Regulatory T cells in cancer immunotherapy, Curr Opin Immunol, 27, 1, 10.1016/j.coi.2013.12.005 Hori, 2003, Control of regulatory T cell development by the transcription factor Foxp3, Science, 299, 1057, 10.1126/science.1079490 Davidsson, 2013, CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer, Mod Pathol, 26, 448, 10.1038/modpathol.2012.164 Peng, 2019, CD8(+) cytotoxic and FoxP3(+) regulatory T lymphocytes serve as prognostic factors in breast cancer, Am J Transl Res, 11, 5039 Shang, 2015, Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis, Sci Rep, 5, 15179, 10.1038/srep15179 Zhu, 2019, Profiles of tumor-infiltrating immune cells in renal cell carcinoma and their clinical implications, Oncol Lett, 18, 5235 Liotta, 2011, Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma, BJU Int, 107, 1500, 10.1111/j.1464-410X.2010.09555.x Griffiths, 2007, Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival, Cancer Immunol Immunother, 56, 1743, 10.1007/s00262-007-0318-z Siddiqui, 2007, Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma, Clin Cancer Res, 13, 2075, 10.1158/1078-0432.CCR-06-2139 Sun, 2017, A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma, Br J Cancer, 117, 1631, 10.1038/bjc.2017.329 Grabowska, 2018, Clinical outcome and time trends of surgically treated renal cell carcinoma between 1986 and 2010: results from a single centre in Sweden, Scand J Urol, 52, 206, 10.1080/21681805.2018.1430706 Hoshida, 2008, Gene expression in fixed tissues and outcome in hepatocellular carcinoma, N Engl J Med, 359, 1995, 10.1056/NEJMoa0804525 Han, 2016, CD163(+) M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma, Int Immunopharmacol, 34, 101, 10.1016/j.intimp.2016.01.023 Liu, 2013, Modulation of macrophage activation and programming in immunity, J Cell Physiol, 228, 502, 10.1002/jcp.24157 Kubota, 2017, CD163(+)CD204(+) tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma, Sci Rep, 7, 1755, 10.1038/s41598-017-01661-z Zhu, 2016, Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer, Oncol Rep, 36, 3472, 10.3892/or.2016.5136 Dannenmann, 2013, Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell carcinoma, Oncoimmunology, 2, e23562, 10.4161/onci.23562 Smith-Bindman, 2019, Trends in use of medical imaging in US health care systems and in Ontario, Canada, 2000-2016, JAMA, 322, 843, 10.1001/jama.2019.11456 Rini, 2019, Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma, N Engl J Med, 380, 1116, 10.1056/NEJMoa1816714 Motzer, 2019, Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial, Lancet Oncol, 20, 1370, 10.1016/S1470-2045(19)30413-9